<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(1)</volume><submitter>Oliver P</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Diabetes mellitus intensify the risks and complications related to COVID-19 infection. A major effect of the pandemic has been a drastic reduction of in-person visits. The aim of this study was to evaluate the impact of the COVID-19 pandemic on HbA&lt;sub>1c&lt;/sub> management and results among pediatric and adult outpatients with diabetes, considering the laboratory and point-of-care testing (POCT) HbA&lt;sub>1c&lt;/sub> measurements.&lt;h4>Methods&lt;/h4>Observational retrospective study including patients from pediatric and adult diabetes units was conducted. HbA&lt;sub>1c&lt;/sub> results obtained in the laboratory and POCT over 3 years (2019-2021) were collected from the laboratory information system.&lt;h4>Results&lt;/h4>After the lockdown, the number of HbA&lt;sub>1c&lt;/sub> plummeted. Children re</pubmed_abstract><journal>Advances in laboratory medicine</journal><pagination>105-119</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10197181</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of COVID-19 pandemic on HbA&lt;sub>1c&lt;/sub> management and results in pediatric and adult outpatients with diabetes.</pubmed_title><pmcid>PMC10197181</pmcid><pubmed_authors>Buno A</pubmed_authors><pubmed_authors>Fernandez-Calle P</pubmed_authors><pubmed_authors>Gonzalez-Casado I</pubmed_authors><pubmed_authors>Mora R</pubmed_authors><pubmed_authors>Tomoiu I</pubmed_authors><pubmed_authors>Diaz-Garzon J</pubmed_authors><pubmed_authors>Gonzalez N</pubmed_authors><pubmed_authors>Pellicer M</pubmed_authors><pubmed_authors>Prieto D</pubmed_authors><pubmed_authors>Losantos I</pubmed_authors><pubmed_authors>Oliver P</pubmed_authors><pubmed_authors>Carcavilla A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of COVID-19 pandemic on HbA&lt;sub>1c&lt;/sub> management and results in pediatric and adult outpatients with diabetes.</name><description>&lt;h4>Objectives&lt;/h4>Diabetes mellitus intensify the risks and complications related to COVID-19 infection. A major effect of the pandemic has been a drastic reduction of in-person visits. The aim of this study was to evaluate the impact of the COVID-19 pandemic on HbA&lt;sub>1c&lt;/sub> management and results among pediatric and adult outpatients with diabetes, considering the laboratory and point-of-care testing (POCT) HbA&lt;sub>1c&lt;/sub> measurements.&lt;h4>Methods&lt;/h4>Observational retrospective study including patients from pediatric and adult diabetes units was conducted. HbA&lt;sub>1c&lt;/sub> results obtained in the laboratory and POCT over 3 years (2019-2021) were collected from the laboratory information system.&lt;h4>Results&lt;/h4>After the lockdown, the number of HbA&lt;sub>1c&lt;/sub> plummeted. Children re</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-04T12:11:14.083Z</modification><creation>2025-04-04T12:11:14.083Z</creation></dates><accession>S-EPMC10197181</accession><cross_references><pubmed>37359900</pubmed><doi>10.1515/almed-2022-0098</doi></cross_references></HashMap>